Research Progress of Natural Compounds from Chinese Herbal Medicine in the Treatment of Melanoma
- PMID: 40372659
- DOI: 10.1007/s11864-025-01322-8
Research Progress of Natural Compounds from Chinese Herbal Medicine in the Treatment of Melanoma
Abstract
Melanoma is a malignant tumor that originates from activated or genetically altered epidermal melanocytes, resulting from the interplay of genetic, somatic, and environmental factors. It is the fastest-growing malignancy among the Caucasian population and has a high mortality rate, second only to lung cancer. Current mainstream treatments have led to unavoidable drug resistance and toxic side effects despite improvements in efficacy and prognosis. Traditional Chinese Medicine is a significant component of complementary and alternative medicine, playing a vital role in cancer treatment. Natural compounds derived from Chinese herbal medicines offer notable advantages owing to their multimolecular, multitarget, and multipathway characteristics. These compounds exert anti-melanoma effects through various mechanisms, including antiproliferation, promotion of apoptosis, inhibition of metastasis, suppression of angiogenesis, modulation of autophagy, and enhancement of the immune response. Furthermore, combining natural compounds with mainstream antagonistic medicine not only enhances treatment efficacy but also significantly reverses multidrug resistance. This article discusses the specific mechanisms by which natural compounds combat melanoma and reviews the recent research advancements in this field. It also addresses the challenges faced in the widespread clinical application of these natural compounds in melanoma treatment and outlines the future directions for their development.
Keywords: Chinese herbal medicine; Mainstream antagonistic medicine; Melanoma; Molecular mechanisms; Natural compounds; Traditional Chinese Medicine.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics Approval: Not applicable. Conflict of Interest: The authors declare no competing interests. Human and Animal Rights and Informed Consent: This article does not contain any studies with human or animal subjects performed by any of the authors.
Similar articles
-
Rabdosia rubescens (Hemsl.) H. Hara: A potent anti-tumor herbal remedy - Botany, phytochemistry, and clinical applications and insights.J Ethnopharmacol. 2025 Jan 31;340:119200. doi: 10.1016/j.jep.2024.119200. Epub 2024 Dec 3. J Ethnopharmacol. 2025. PMID: 39631716
-
Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases.Phytomedicine. 2024 Jul 25;130:155738. doi: 10.1016/j.phymed.2024.155738. Epub 2024 Jun 1. Phytomedicine. 2024. PMID: 38824825
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer.J Ethnopharmacol. 2021 Feb 10;266:113430. doi: 10.1016/j.jep.2020.113430. Epub 2020 Oct 2. J Ethnopharmacol. 2021. PMID: 33011366
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
References
-
- Crawford NG, Kelly DE, Hansen MEB, et al. Loci associated with skin pigmentation identified in African populations. Sci. 2017;358(6365):eaan8433.
-
- Lazaroff J, Bolotin D. Targeted Therapy and Immunotherapy in Melanoma. Dermatol Clin. 2023;41(1):65–77. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical